Funding Opportunities: Rapid Acceleration of Diagnostics Radical (RADx-rad) Emergency Awards


We’ve joined the NIH Office of the Director and several institutes in two Rapid Acceleration of Diagnostics Radical (RADx-rad) initiative funding opportunity announcements (FOAs). These FOAs offer an excellent opportunity for NIGMS-supported researchers with expertise in technology development and/or artificial intelligence/machine learning to conduct innovative research addressing the public health emergency caused by COVID-19.

  • RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01-Clinical Trials Not Allowed)
    Solicits cooperative agreements for field studies and small business research on optimal sampling and testing of wastewater to map the extent and spread of COVID-19. Specific areas of research interest for NIGMS are technology development; incorporation of computational, statistical, and mathematical models; and use of artificial intelligence/machine learning.
    Application deadline: September 16, 2020

  • RADx-rad Multimodal COVID-19 Surveillance Methods for High Risk Clustered Populations (R01 Clinical Trial Optional)
    Invites applicants to pursue development and validation studies of COVID-19 surveillance methods in settings and institutions, including residential, with a high density of people who are together for prolonged periods. This FOA does not support studies focused on direct viral testing of individuals. Specific areas of research interest for NIGMS are the development of computational, statistical, and mathematical models and the use of artificial intelligence/machine learning for COVID-19 surveillance.
    Application deadline: September 30, 2020

The funding for these initiatives is provided by the Paycheck Protection Program and Health Care Enhancement Act, 2020.

If you have any questions about these programs, please contact Julia Barthold for RFA-OD-20-015 and Behrous Davani for RFA-OD-20-016.

Submit a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.